Synthetic lethality and PARP-inhibitors in oral and head & neck cancer.

Abstract:

:Head and neck cancer refers to a group of malignancies that affects the epithelium of the upper aereodigestive tract, primarily the lip and mouth, pharynx and larynx. Head and neck cancer is strongly associated with tobacco smoking, alcohol consumption and betel nut chewing, and indeed a reduction in the exposure to these risk factors has determined a recent decrease in incidence rates in many countries. There remains, however, a significant increase in head and neck cancer rates in those regions where tobacco epidemic continues, as well as in the number of oral cancers related to HPV infection (in particular cancer of the oropharynx, tonsil, and base of the tongue), which typically affect young adults with no history of exposure to tobacco or alcohol. Treatment of head and neck cancer has significantly changed during the last few decades, and an increasing number of individuals are currently offered combined chemoradiotherapy as single treatment modality for organ preservation or in association with surgery to improve prognosis. Unfortunately, the majority of head and neck cancer patients eventually succumb to their disease, with inoperable locoregional recurrences and lack of response to chemoradiotherapy representing the main causes of death. There is an urgent need of novel molecular-targeted therapeutics that could overcome the limitations of current treatment modalities. This paper reviews the characteristics of a novel group of promising antineoplastic agents, poly (ADP-ribose) polymerases (PARP) inhibitors, which cleverly target one of the mechanisms cancer cells use to escape the toxic effect of chemoradiation, and describe the potential benefits of their addition to current limited range of head and neck cancer antineoplastic agents.

journal_name

Curr Pharm Des

authors

Forster M,Mendes R,Fedele S

doi

10.2174/138161212803307608

subject

Has Abstract

pub_date

2012-01-01 00:00:00

pages

5431-41

issue

34

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-20120525-17

journal_volume

18

pub_type

杂志文章,评审
  • Gastroduodenal safety of cyclooxygenase-2 inhibitors.

    abstract::Cyclooxygenase-1 (COX-1) derived eicosanoids promote gastroprotective mucosal defenses and induce platelet aggregation. By sparing COX-1, COX-2 specific inhibitors provide effective anti-inflammatory and analgesic activity while substantially reducing the risk of peptic ulcer disease and GI bleeding compared to dual C...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033454018

    authors: Scheiman JM

    更新日期:2003-01-01 00:00:00

  • Syngonanthus nitens (Bong.) Ruhland Derivatives Loaded into a Lipid Nanoemulsion for Enhanced Antifungal Activity Against Candida parapsilosis.

    abstract:BACKGROUND:Vaginal infections caused by non-albicans species have become common in women of all age groups. The resistance of species such as Candida parapsilosis to the various antifungal agents is a risk factor attributed to these types of infections, which instigates the search for new sources of active compounds in...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200317131041

    authors: C de Lima L,A S Ramos M,Toledo LG,Rodero CF,Hilário F,Dos Santos LC,Chorilli M,Bauab TM

    更新日期:2020-01-01 00:00:00

  • Genomes to hits in silico - a country path today, a highway tomorrow: a case study of chikungunya.

    abstract::These are exciting times for bioinformaticians, computational biologists and drug designers with the genome and proteome sequences and related structural databases growing at an accelerated pace. The post-genomic era has triggered high expectations for a rapid and successful treatment of diseases. However, in this bio...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990379

    authors: Soni A,Pandey KM,Ray P,Jayaram B

    更新日期:2013-01-01 00:00:00

  • Veterinary vaccines from transgenic plants: highlights of two decades of research and a promising example.

    abstract::In the last two decades the development of efficient plant-based expression strategies and new concepts for the purification of recombinant proteins prompted the application of plant-derived vaccines for veterinary purposes. The expression of recombinant proteins in plants possesses advantages over conventional eukary...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319310014

    authors: Phan HT,Floss DM,Conrad U

    更新日期:2013-01-01 00:00:00

  • The Application of Microfluidic Techniques on Tissue Engineering in Orthopaedics.

    abstract:BACKGROUND:Tissue engineering (TE) is a promising solution for orthopaedic diseases such as bone or cartilage defects and bone metastasis. Cell culture in vitro and scaffold fabrication are two main parts of TE, but these two methods both have their own limitations. The static cell culture medium is unable to achieve m...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190301142833

    authors: Wang L,Jiang D,Wang Q,Wang Q,Hu H,Jia W

    更新日期:2018-01-01 00:00:00

  • Medical management of the diabetic patient with coronary artery disease.

    abstract::The prevalence of type 2 diabetes is rising at an alarming rate worldwide. Coronary artery disease (CAD) is the leading cause of morbidity and mortality in the diabetic population. Future CAD risk should be routinely assessed in patients with diabetes as specific subgroups might benefit from information derived from c...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208786071272

    authors: Karastergiou K,Kaski JC

    更新日期:2008-01-01 00:00:00

  • Organotin(IV) Carboxylates as Promising Potential Drug Candidates in the Field of Cancer Chemotherapy.

    abstract::Medicinal inorganic chemistry plays an important role in exploring the properties of metal ions for the designing of new drugs. The field has been stimulated by the success of cis-platin, the world best selling anticancer drug and platinum complexes with reduced toxicity, oral activity and activity against resistant t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160906143249

    authors: Sirajuddin M,Ali S

    更新日期:2016-01-01 00:00:00

  • Novel targets for cardiac antiarrhythmic drug development.

    abstract::Cardiac arrhythmias remain a major source of morbidity and mortality in developed countries. Antiarrhythmic drug therapy was traditionally the mainstay of cardiac arrhythmia treatment; however, drug therapy of cardiac arrhythmias has been plagued by incomplete efficacy and by potentially serious adverse reactions, of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612054021051

    authors: Hesketh JC,Herrera D,Zicha S,Nattel S

    更新日期:2005-01-01 00:00:00

  • BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.

    abstract::Commonly, the angiogenic growth factors signify healing. However, gastrointestinal ulceration is still poorly understood particularly with respect to a general pharmacological/pathophysiological role of various angiogenic growth factors implemented in growth factors wound healing concept. Thereby, we focused on the st...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180712110447

    authors: Seiwerth S,Rucman R,Turkovic B,Sever M,Klicek R,Radic B,Drmic D,Stupnisek M,Misic M,Vuletic LB,Pavlov KH,Barisic I,Kokot A,Japjec M,Blagaic AB,Tvrdeic A,Rokotov DS,Vrcic H,Staresinic M,Sebecic B,Sikiric P

    更新日期:2018-01-01 00:00:00

  • Effects of metabolic approach in diabetic patients with coronary artery disease.

    abstract::The pivotal therapeutic role of myocardial metabolic modulation in ischemic heart disease (IHD) is increasingly recognized. Among the others, inhibitors of free fatty acids (FFA) oxidation have been consistently shown to play an important role in the therapeutic strategy of IHD patients. Additionally, abnormalities of...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209787582093

    authors: Fragasso G,Salerno A,Spoladore R,Cera M,Montanaro C,Margonato A

    更新日期:2009-01-01 00:00:00

  • The influence of natural substrates and inhibitors on the nucleotide-dependent excision activity of HIV-1 reverse transcriptase in the infected cell.

    abstract::Human immunodeficiency virus type 1 resistance to nucleoside reverse transcriptase inhibitors such as 3'-azido-2', 3'-dideoxythymidine (AZT) can arise through mutations in the coding region of reverse transcriptase (RT) that enhance the enzyme's ability to remove the drug after it has been incorporated. This excision ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206776873572

    authors: Smith AJ,Scott WA

    更新日期:2006-01-01 00:00:00

  • An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development.

    abstract::A severe atypical pneumonia designated as severe acute respiratory syndrome (SARS) by The World Health Organization broke out in China and menaced to more than other 30 countries between the end of the year 2002 and June of the year 2003. A novel coronavirus called severe acute respiratory syndrome coronavirus (SARS-C...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206779010459

    authors: Chen S,Luo H,Chen L,Chen J,Shen J,Zhu W,Chen K,Shen X,Jiang H

    更新日期:2006-01-01 00:00:00

  • Towards histone deacetylase inhibitors as new antimalarial drugs.

    abstract::Histone deacetylases (HDACs) are important enzymes that effect post-translational modifications of proteins by altering the acetylation state of lysine residues. HDACs control epigenetic changes that trigger cell transformation and proliferation of transformed cells associated with many diseases. These enzymes are val...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Andrews KT,Tran TN,Fairlie DP

    更新日期:2012-01-01 00:00:00

  • Edible Mushrooms: Novel Medicinal Agents to Combat Metabolic Syndrome and Associated Diseases.

    abstract::Metabolic syndrome is an aggregation of conditions and associated with an increased risk of developing diabetes, obesity and cardiovascular diseases (CVD). Edible mushrooms are widely consumed in many countries and are valuable components of the diet because of their attractive taste, aroma, and nutritional value. Med...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200831151316

    authors: Tung YT,Pan CH,Chien YW,Huang HY

    更新日期:2020-01-01 00:00:00

  • The role of bevacizumab in advanced epithelial ovarian cancer.

    abstract:BACKGROUND:There is a strong rationale for usage of anti-angiogenic agents in epithelial ovarian cancer. Bevacizumab is the most widely investigated anti-VEGF agent and has shown promising results in recent clinical trials. OBJECTIVE:To review the rationale and usage of bevacizumab in advanced epithelial ovarian cance...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161212802002689

    authors: Kroep JR,Nortier JW

    更新日期:2012-01-01 00:00:00

  • Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes.

    abstract::It is generally accepted that mitochondrial dysfunction and endoplasmic reticulum (ER) stress are related to insulin resistance and type 2 diabetes. Mitochondria use substrates from lipid and glucose metabolism in order to generate ATP, and when mitochondrial O2 consumption is decreased due to an altered metabolism th...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160209152033

    authors: Rocha M,Diaz-Morales N,Rovira-Llopis S,Escribano-Lopez I,Bañuls C,Hernandez-Mijares A,Diamanti-Kandarakis E,Victor VM

    更新日期:2016-01-01 00:00:00

  • PET imaging in clinical drug abuse research.

    abstract::Over the last two decades, SPECT (single photon emission computed tomography) and especially PET (positron emission tomography) have proven increasingly effective imaging modalities in the study of human psychopharmacology. Abusing populations can be studied at multiple times after abstinence begins, to give informati...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161205774424717

    authors: Gatley SJ,Volkow ND,Wang GJ,Fowler JS,Logan J,Ding YS,Gerasimov M

    更新日期:2005-01-01 00:00:00

  • Cardio-protective effects of sodium-glucose co-transporter 2 inhibitors: focus on heart failure.

    abstract:BACKGROUND:Type 2 diabetes mellitus (DM) is associated with a considerable risk of cardiovascular and renal disease, including heart failure. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated unprecedented cardiorenal protective effects in large scale clinical trials of patients with or without diabet...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666201103122813

    authors: Karangelis D,Mazer CD,Stakos D,Tzifa A,Loggos S,Verma S,Mitropoulos F

    更新日期:2020-11-03 00:00:00

  • Regulation of angiogenesis by the kallikrein-kinin system.

    abstract::High molecular weight kininogen (HK) is a plasma protein that is cleaved by plasma kallikrein in the clinical settings of sepsis and chronic inflammatory diseases such as rheumatoid arthritis and Crohn's disease. This proteolytic event results in a nonapeptide, bradykinin (BK), and a kinin-free derivative of HK, namel...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206777698710

    authors: Colman RW

    更新日期:2006-01-01 00:00:00

  • Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach.

    abstract::The involvement of the central nervous system (CNS) is one of the major causes of morbidity and mortality in systemic lupus erythematosus (SLE) patients and the less understood aspect of the disease. Its recognition and treatment continue to represent a major diagnostic and therapeutic challenge. Due to the lack of co...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208799316401

    authors: Sanna G,Bertolaccini ML,Khamashta MA

    更新日期:2008-01-01 00:00:00

  • Anticancer agents: tumor cell growth inhibitory activity and binary QSAR analysis.

    abstract::The tumor cell growth inhibitory activities (log 1/GI(50)) of 166 anticancer agents studied at the National Cancer Institute (NCI) in vitro anticancer screening program have allowed us to analyze the relative importance of physicochemical parameters in influencing the inhibitory activities. Increased molecular weight,...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612043384925

    authors: Ren SS,Lien EJ

    更新日期:2004-01-01 00:00:00

  • Therapy of elderly/comorbid patients with chronic lymphocytic leukemia.

    abstract::Treatment of chronic lymphocytic leukemia (CLL) has recently undergone revolutionary changes. Two large randomized trials demonstrated superiority of chemoimmunotherapy combining fludarabine and cyclophosphamide with monoclonal anti-CD20 antibody rituximab (FCR) over fludarabine and cyclophosphamide (FC) alone in firs...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212801227096

    authors: Smolej L

    更新日期:2012-01-01 00:00:00

  • Multilevel Analysis of Locomotion in Immature Preparations Suggests Innovative Strategies to Reactivate Stepping after Spinal Cord Injury.

    abstract::Locomotion is one of the most complex motor behaviors. Locomotor patterns change during early life, reflecting development of numerous peripheral and hierarchically organized central structures. Among them, the spinal cord is of particular interest since it houses the central pattern generator (CPG) for locomotion. Th...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161214151051

    authors: Brumley MR,Guertin PA,Taccola G

    更新日期:2017-01-01 00:00:00

  • Hormones and Sarcopenia.

    abstract::Sarcopenia is defined as the loss of muscle mass associated with a loss of muscle function, e.g., walking speed. A number of consensus definitions exist for sarcopenia with cut-off points being ethnically specific. A rapid screen test (SARC-F) is available and does not require different ethnic cut-off points. Sarcopen...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666161123150032

    authors: Morley JE

    更新日期:2017-11-28 00:00:00

  • Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature.

    abstract::Both high arterial blood pressure (BP) and elevated levels of fine particulate matter (PM2.5) air pollution have been associated with an increased risk for several cardiovascular (CV) diseases, including stroke, heart failure, and myocardial infarction. Given that PM2.5 and high BP are each independently leading risk ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151109111712

    authors: Giorgini P,Di Giosia P,Grassi D,Rubenfire M,Brook RD,Ferri C

    更新日期:2016-01-01 00:00:00

  • Correlation of Salusin Beta with hs-CRP and ADMA in Hypertensive Children and Adolescents.

    abstract:PURPOSE:The emerging evidence has recently shown an evident dependence between recently identified salusin peptides and atherosclerosis, and their important roles as endogenous modulators of atherogenesis. It was reported that the development of atherosclerosis could also be affected by endogenous salusin- β overproduc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612824666180607124531

    authors: Kołakowska U,Kuroczycka-Saniutycz E,Olański W,Wasilewska A

    更新日期:2018-01-01 00:00:00

  • Biochemical markers of autoimmune diseases of the nervous system.

    abstract::Biochemical biomarkers are important candidates for the diagnosis and prognosis of neurological diseases of autoimmune etiology, since they may reflect the presence, nature and intensity of certain immune responses caused by both genetic and environmental processes. Different body fluids such as cerebrospinal fluid (C...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212802502143

    authors: Tumani H,Brettschneider J

    更新日期:2012-01-01 00:00:00

  • Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?

    abstract::While pharmacological blockade of dopamine D2 receptor can effectively suppress the psychotic or positive symptoms of schizophrenia, there is no satisfactory medication for the negative and cognitive symptoms of schizophrenia in spite of the proliferation of second generation antipsychotic drugs. Excitements over a ne...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150724100952

    authors: Singer P,Dubroqua S,Yee BK

    更新日期:2015-01-01 00:00:00

  • Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects.

    abstract::Vascular endothelial growth factor (VEGF) is one of the main endogenous pro-angiogenic cytokines. Inhibition of the VEGF signaling pathways is an effective treatment for cancer patients. In addition, local anti- VEGF therapy was developed and established to treat proliferative diabetic retinopathy, age-related macular...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150225120314

    authors: van der Giet M,Henkel C,Schuchardt M,Tolle M

    更新日期:2015-01-01 00:00:00

  • GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.

    abstract::In the mid seventies a drug design programme using the Amanita muscaria constituent muscimol (7) as a lead structure, led to the design of guvacine (23) and (R)-nipecotic acid (24) as specific GABA uptake inhibitors and the isomeric compounds isoguvacine (10) and isonipecotic acid (11) as specific GABAA receptor agoni...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612003399608

    authors: Krogsgaard-Larsen P,Frølund B,Frydenvang K

    更新日期:2000-08-01 00:00:00